According to market observers, Senores Pharmaceuticals IPO GMP is signaling 73% listing gain for the lucky allottees

Senores Pharmaceuticals IPO subscription status Senores Pharmaceuticals fetched 51.13 times subscriptions on the final day of the share sale. The Non-Institutional Investors part

The basis of allotment for Senores Pharmaceuticals IPO shares is set to be finalised on Thursday, December 26, 2024. Investors who subscribed to the public offering can check their allotment status on the official websites of BSE,

Ventive Hospitality, Senores Pharmaceuticals, and Carraro India IPOs will list on December 30. Senores Pharmaceuticals has a 93.69 times subscription, while Ventive shows a positive grey market premium.

Investors can check their allotment by visiting the websites of the Bombay Stock Exchange (BSE) or Link Intime India.

The grey market premium of Senores Pharmaceuticals was Rs 220 as of 4:28 p.m. on Monday, according to Chittorgarh's unit InvestorGain. The estimated listing price based on the GMP is Rs 611 per share, implying a premium of 56.27%.

According to stock market observers, shares of the company are available at a premium of ₹242 in the grey market today

Investors can check their allotment status through multiple platforms such as NSE, BSE and also through the registrar’s website Link Intime. Here is the step-by-step guide to check your allotment status on each website. Create an account by registering with your details or log in if you already have one.

Senores Pharmaceuticals' IPO witnessed an impressive 13.88 times subscription, amassing bids for 11.8 crore shares compared to the 85.3 lakh shares offered. Retail investors subscribed 38.34 times, while non-institutional investors applied 24.